Lead Product(s) : Dasiglucagon
Therapeutic Area : Endocrinology
Study Phase : Phase II/ Phase III
Sponsor : Beta Bionics | Zealand Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
The Bihormonal iLet Bionic Pancreas Feasibility Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
February 15, 2019
Lead Product(s) : Dasiglucagon
Therapeutic Area : Endocrinology
Highest Development Status : Phase II/ Phase III
Sponsor : Beta Bionics | Zealand Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Study Phase : Phase IV
Recipient : GSK
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
June 16, 2016
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Highest Development Status : Phase IV
Recipient : GSK
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Testosterone
Therapeutic Area : Endocrinology
Study Phase : Phase II
Sponsor : Endo Pharm | Merck & Co
Deal Size : Inapplicable
Deal Type : Inapplicable
Testosterone and Alendronate in Hypogonadal Men
Details : Undisclosed
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
October 27, 2011
Lead Product(s) : Testosterone
Therapeutic Area : Endocrinology
Highest Development Status : Phase II
Sponsor : Endo Pharm | Merck & Co
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
